OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceGlobeNewsWire • 08/07/25
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?Zacks Investment Research • 07/25/25
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ETGlobeNewsWire • 07/17/25
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?Zacks Investment Research • 07/16/25
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?Zacks Investment Research • 07/11/25
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?Zacks Investment Research • 07/04/25
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to BuyZacks Investment Research • 06/06/25
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceGlobeNewsWire • 05/12/25
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ETGlobeNewsWire • 04/23/25
OptimizeRx Corporation Announces Plan for Additional Board of Directors RefreshmentGlobeNewsWire • 04/18/25
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 MillionBenzinga • 03/12/25
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewsWire • 03/12/25